Upstream Manufacturing Solutions
-
Clone, Strain, And Viral Construct Screening Executed For You
4/24/2024
Evaluate your clones, strains, and viral constructs in our bioreactors with flexible scale out.
Benefits
Select the best clone by evaluating larger experimental cohorts
Make the most informed, data-driven selection by leveraging our fleet of 250mL and 5L Culture bioreactors to screen your clones, strains and viral constructs.
Defer your capital equipment spend
Evaluate your clones, strains and viral constructs without the need for new capital equipment.
Transparent, real-time data provided by a team of experts
Painless technology transfer with live data relayed via our cloud-connected systems. We have >95% success rate with >22,000 runs successfully executed.
-
Leverage Bioreactor Capacity When You Need It With Culture Bioreactors
4/24/2024
Gain access to Culture bioreactors when you need rapid overflow experimental capacity.
Benefits
Progress studies faster
Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.
Stay agile in your capacity planning
Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.
Eliminate your capital equipment spend
Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.
-
Bioreactors And DOE expertise To Characterize Your Process Prior To PPQ
4/18/2024
Assess your process in scale-down bioreactors that allow for increased model curvature and variables in your process DOEs.
-
Cutting-Edge Solution To Streamline Your CLD Workflow
4/16/2024
Discover a cutting-edge approach that enables you to screen for glycans at every stage of CLD and streamline your workflow.
-
An NGS-Based Platform To Streamline Your Genetic Stability Testing
4/11/2024
Discover an assay that leverages the power of whole genome sequencing and expert bioinformatics to deliver a faster, all-in-one solution for a comprehensive testing package.
-
THESYS Oligosynthesizers For Solid Phase Oligonucleotide Synthesis
3/26/2024
Learn about high-performance and scalable THESYS OS oligosynthesizers, which feature advanced process controls and automation for efficient and reliable oligonucleotide synthesis.
-
Producer Cell Line To Elevate Your AAV Production To The Next Level
3/6/2024
Discover a true producer cell line where Rep, Helper, Cap, and the gene of interest are stably integrated into the host cell's genome, requiring only a single induction step to initiate AAV production.
-
A Stable Cell Line For Inducible AAV Production
3/6/2024
Delivering on the promise of AAV-based gene therapies beyond rare diseases will require large quantities of high-quality AAV, produced in a robust manner.
-
Banking The Intensified Seed Train
3/4/2024
Explore seed train intensification, a transformative approach to cell culturing, and process solutions that enable you to amplify your cell banks.
-
Spent Media Analytics: Unlock New Process Insights
2/21/2024
Our services gather information about amino acids, trace elements, water-soluble vitamins and other analytes of interest e. g. glucose, lactate, and ammonium present in your sample